Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
01/2001
01/31/2001EP1071790A1 Phytic acid biosynthetic enzymes
01/31/2001EP1071789A1 Phytic acid biosynthetic enzymes
01/31/2001EP1071788A1 Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase
01/31/2001EP1071787A1 Tao protein kinases and methods of use
01/31/2001EP1071786A2 Genetically engineered yeast and mutants thereof for the efficient fermentation of lignocellulose hydrolysates
01/31/2001EP1071785A2 Interconversion of plant fatty acid desaturases and hydroxylases
01/31/2001EP1071782A2 Seed-coat promoters, genes and gene products
01/31/2001EP1071769A1 Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence
01/31/2001EP1071762A1 Control of gene expression
01/31/2001EP1071760A1 Genetically modified lactic acid bacteria having modified diacetyl reductase activities
01/31/2001EP1071759A1 Assay methods for modulators of hematopoietic cell phosphatase
01/31/2001EP1071756A1 PURIFICATION OF HUMAN ACID $g(a)-GLUCOSIDASE
01/31/2001EP1071755A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep
01/31/2001EP1071754A1 Recombinant secoisolariciresinol dehydrogenase, and methods of use
01/31/2001EP1071753A2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
01/31/2001EP1071746A2 Process for preparing doxorubicin
01/31/2001EP1071706A1 Rapidly degrading gfp-fusion proteins and methods of use
01/31/2001EP1071700A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
01/31/2001EP1071697A1 Regulated target expression for screening
01/31/2001EP1071696A1 Programmed cell death and caspase-12
01/31/2001EP1071471A2 Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene
01/31/2001EP1071334A1 A method for efficient and highly selective control of microorganisms
01/31/2001EP0920528A4 Synthetic protein folding catalysis
01/31/2001EP0706569B1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof
01/31/2001EP0592583B1 Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse
01/31/2001CN1282389A Continuous biopolishing of cellulose-containing fabrics
01/31/2001CN1282373A Method for producing amylase enzymes
01/31/2001CN1282370A Matrix granule
01/31/2001CN1282369A Polypeptides having aminopepyidase activity and nucleic acids encoding same
01/31/2001CN1282367A Granule with hydrated barrier material
01/30/2001US6180850 Ku70 is the noncatalytic subunit of dna-protein kinase, encoded by specified polynucleotides; transgenic plants; modulating the level of ku70 in a plant; modulating nucleic acid expression in plants
01/30/2001US6180766 Nucleosides and oligonucleotides containing boron clusters
01/30/2001US6180619 Prenyl transferase inhibitors
01/30/2001US6180613 AAV-mediated delivery of DNA to cells of the nervous system
01/30/2001US6180612 Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives
01/30/2001US6180602 Derived from mrnas expressed in human cells
01/30/2001US6180406 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
01/30/2001US6180399 Synthetic rna having endonuclease activity and altered substrate binding site; for multifunctional enzyme
01/30/2001US6180390 Pseudonocardia; for the fermentation of hydrolase polypeptide
01/30/2001US6180388 Process for the enzymatic hydrolysis of polyamide 6.6 to give adipic acid monomers and hexamethylenediamine monomers
01/30/2001US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection
01/30/2001US6180386 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1beta converting enzyme
01/30/2001US6180385 Nucleotide sequences coding a viral enzymatic polypeptide; for the detection of modulators of proteolytic activity
01/30/2001US6180384 Compounds
01/30/2001US6180383 Insect proteolytic enzyme; for the prevention of insect infestation
01/30/2001US6180382 Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organisms therefor and use thereof
01/30/2001US6180381 Pseudomonas chlororaphis microorganism, polyurethane degrading enzyme obtained therefrom, and method of use
01/30/2001US6180380 Cloning of a new member of the serine threonine kinase family
01/30/2001US6180379 Eukaryotic transport protein; for utilization in the ubiquination and degradation of cell cycle polypeptides
01/30/2001US6180378 Immobilization of bioactive protein in phyllosilicates
01/30/2001US6180367 Recovering heterologous proteins from microorganisms; culture transformed microorganismal cells with expression vector, incubate with inducer, propagate, lyse cells and recover accumulated heterologous protein
01/30/2001US6180366 Methods for producing heterologous polypeptides in trichothecene-deficient
01/30/2001US6180363 Recoding of DNA sequences permitting expression in yeast and obtained transformed yeast
01/30/2001US6180361 Recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporin C synthetase and deacetylcephalosporin C synthetase
01/30/2001US6180360 Process of producing β-lactam antibiotics applying micro-organisms with increased ligase activity
01/30/2001US6180359 Industrial scale process for the preparation of 2-hydroxy-4-methylbutyric acid using a nitrilase
01/30/2001US6180358 Detecting modulators of kinase activity; incubate modulator with cells expressing kinase polypeptide, detect modulation of kinase activity
01/30/2001US6180343 Green fluorescent protein fusions with random peptides
01/30/2001US6180342 Vacuolar proton ATPase subunits
01/30/2001US6180336 Labelling and selection of molecules
01/30/2001US6180334 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of ‘aggrecanase’ in cell culture systems
01/30/2001CA2238098C Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis
01/30/2001CA2139931C Purification of factor ix
01/27/2001CA2314569A1 Methods for treating skin pigmentation
01/25/2001WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6
01/25/2001WO2001005996A1 Process for producing optically active pyridineethanol derivatives
01/25/2001WO2001005984A2 Flavonoid biosynthesis
01/25/2001WO2001005983A1 Dsp-11 dual-specificity map kinase phosphatase
01/25/2001WO2001005982A1 Method for the production of l-amino acids from their racemic n-acetyl-d, l-derivatives by enzymatic racemate cleavage by means of isolated recombinant enzymes
01/25/2001WO2001005980A1 Compositions and methods for fumonisin detoxification
01/25/2001WO2001005979A1 Process for producing target substance by fermentation method
01/25/2001WO2001005975A1 MAIZE ORTHOLOGUES OF BACTERIAL RuvB:cDNAS AND USES THEREOF
01/25/2001WO2001005961A1 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
01/25/2001WO2001005956A2 Sialyation of n-linked glycoproteins in the baculovirus expression vector system
01/25/2001WO2001005954A1 Antisense modulation of liver glycogen phosphorylase expression
01/25/2001WO2001005952A2 Plant genes
01/25/2001WO2001005949A1 Membrane separation process for purifying, concentrating and densifying enzyme solutions with polyols
01/25/2001WO2001005948A1 Assay of the activation state of platelets
01/25/2001WO2001005837A1 Method for assaying compounds affecting smooth muscle contractile state
01/25/2001WO2001005826A2 Chimeric polypeptides of serum albumin and uses related thereto
01/25/2001WO2001005823A2 Tryptase inhibitor
01/25/2001WO2001005811A2 Cyclic peptidomimetic urokinase receptor antagonists
01/25/2001WO2001005772A1 Pyrazinones, compositions containing such compounds
01/25/2001WO2001005419A2 Agent for treating cardiac diseases
01/25/2001WO2001005405A1 Folylpolyglutamyl synthetase gene transfer to enhance antifolate drug sensitivity
01/25/2001WO2001005353A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
01/25/2001WO2000068399A3 Vector-mediated delivery of integrating transposon sequences
01/25/2001WO2000068240A8 NOVEL aroA
01/25/2001WO2000061787A3 gyrA
01/25/2001WO2000061763A3 Proteins related to gaba metabolism
01/25/2001WO2000058486A3 Maize ku80 homolog and uses thereof
01/25/2001WO2000057837A3 Compositions and methods for effecting the levels of cholesterol
01/25/2001WO2000050616A3 Sequences for improving the efficiency of secretion of non-secreted proteins from mammalian and insect cells
01/25/2001WO2000049139A3 A caspase activated protein kinase
01/25/2001WO2000047728A3 Soybean glutathione-s-transferase enzymes
01/25/2001WO2000042196A3 Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, cancer, and down's syndrome
01/25/2001DE19934408A1 New fungal orotic acid phosphoribosyltransferase gene, useful as a selection marker in recombinant protein expression systems
01/25/2001DE19933701A1 Zyklische peptidomimetische Urokinaserezeptorantagonisten Cyclic peptidomimetic Urokinaserezeptorantagonisten
01/25/2001CA2379983A1 Dsp-11 dual-specificity map kinase phosphatase
01/25/2001CA2379849A1 Process for the preparation of l-amino acids from their racemic n-acetyl-d,l derivatives by enzymatic resolution by means of isolated, recombinant enzymes